Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls42_0002.txt
Subject: AAR MEETING WORKING GROUP MEDICAL DEFENSE AGAINST BIO WAR
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: AAR MEETING OF THE AD HOC WORKING GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE-5
Document Number: 1
Folder SEQ #: 172
UNCLASSIFIED
its use is obtained. They will brief theater medical pei
on the vaccine and oversee the vaccination program.
a. At the request of The Surgeon General, Depa3
of the Army, the Disease Control Subcommittee of the Arm,
Forces Epidemiology Board met on 29 August 1990. Based i
the information presented to the committee, the board
recommended the use of anthrax immunization to operation t m
Shield Forces, botulinum toxoid immunization of selected
operation Desert Shield Forces, and continuing medical
education and training for medical personnel assigned to
operation Desert Shield (Encl 3).
f. Discussion of Unresolved Issues from 20 Aug
meeting.
(1) (U) Placement of a Special Laboratory to Me m
Accurate and Timely Diagnosis of Endemic and BW Threat Di a
- Placement of a laboratory as close to the AO as possib]
Short-term fix may be supplementing the resources of the
Medical Laboratory: USAMRDC will place one team consist f
2 or 3 individuals and equipment at the 10th Medical Labc y
and another at an in-country location. These teams will I
the responsibility to provide rapid diagnostic capability r
the identification of both endemic disease and those caus
Bw agents. In addition, they will train on-site personne
The Navy will also supplement the staff at their Cairo fa y
and establish a second diagnostic facility in-theater.
(2) (U) Efficacy of Pre-Exposure and Post-ExpoE
Antibiotic/Antitoxin - challenge studies performed at UE D
to address this issue: Currently, the Ad Hoc Committeals
recommendation is that if BW exposure is imminent,
n la should begin chemodrophylaxis with
series. Prophyiaxis alone given post-exposure seems to t
little benefit. USAMRIID is conducting challenge studies
address this issue.
(3) (U) Jet Injector - Can the Jet Injector be
to administer the Anthrax Vaccine: USAMRDC stated the je
injector could not be used to administer the anthrax vacc
(4) (U) Guidance for BW Countermeasures - The
preparation of written guidance to the field on various i
associated with the medical aspects of BW: The Internal
Medicine Consultant, the Infectious Disease Consultant, t
Disease Control Consultant, USAMRDC, etc., are preparing
document which will be provided to medical personnel in-t
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 5 f:/Week-36/BX003203/AAR MEETING OF THE AD HOC WORKING GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE-5/aar meeting working group medical defense agains:11089615093343
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = AAR MEETING OF THE AD HOC WORKING GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE-5
Folder Seq # = 172
Subject = AAR MEETING WORKING GROUP MEDICAL DEFENSE AGAINS
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996